Our results suggest that IRE1 blockade protects from chemotherapy‐induced cardiotoxicity without reducing anti‐tumor effects and, in the context of obesity, may enhance anticancer chemotherapy efficacy. This evidence concerns the gene ERN1 and obesity due to melanocortin 4 receptor deficiency.